Researchers have used CRISPR to switch back on a gene that vanished from the human lineage roughly 20 million years ago, reviving a natural defense against excess uric acid that our ancestors once ...

Houston center Alperen Sengun left the Rockets’ loss to Dallas on Saturday night only 1:04 into play after spraining his ...

A somewhat uncommon procedure is proving to be an effective solution for problems associated with ankle arthritis.

Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire Arthrosi Therapeutics, a startup with a gout drug candidate in Phase 3 ...

Expands Sobi's pipeline with a highly differentiated new Phase 3 asset in Gout Acquisition expected to be highly accretive to Sobi's mid- to long-term growth and margin trajectory STOCKHOLM, Dec. 13, ...

Gout is a type of arthritis that is caused by the accumulation of uric acid in the body. Crystals of uric acid can form in a joint and this can lead to intense pain and inflammation. While, gout is ...

- Acquisition expected to be highly accretive to Sobi's mid- to long-term growth and margin trajectory "The acquisition of Arthrosi allows us to expand our gout pipeline with a highly differentiated ...

Drugmaker Swedish Orphan Biovitrum said on Saturday it had agreed to acquire U.S.-based biotechnology company Arthrosi Therapeutics for up to $1.5 billion to strengthen its portfolio of gout ...

Although the incidence of gout could be similar in men and women >60 years of age, most research has focused on the epidemiology and treatment of this disease in men. Harrold and colleagues have ...

Several agents are available and generally effective for the treatment of gout; however, many are poorly tolerated, or contraindicated in patients with renal, cardiovascular or gastrointestinal ...